MentionFox
Home › Acquisitions › Synergy Empire Ltd
Completed acquisition · SEC Form 8-K, Item 2.01

Synergy Empire Ltd acquisition of Meluha Therapeutics Berhad

From Synergy Empire Ltd's Form 8-K/A of 2026-07-06, quoted and linked below.

Synergy Empire Ltd completed its acquisition of Meluha Therapeutics Berhad on 2025-03-28, according to the Form 8-K/A Synergy Empire Ltd filed with the SEC on 2026-07-06. The filing states a price of $2.2 million.

AcquirerSynergy Empire Ltd
AcquiredMeluha Therapeutics Berhad
Completed2025-03-28
Price stated in the filing$2.2 million
Reported bySynergy Empire Ltd, the buyer
FilingForm 8-K/A, filed 2026-07-06

Want the whole picture on Synergy Empire Ltd?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Synergy Empire Ltd: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Synergy Empire Ltd covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on Target: the verdict, 16 sections, 39 cited sources, dated 2026-09-28A real finished report, first screen. Opens in a new tab.

What the filing says

We consummated the acquisition of Meluha on March 28, 2025.

The price, in the filing's words

As a consideration, we agreed to issue to the shareholders of Meluha, 10,000,000 shares of our series A preferred stock with par value of $0.0001 per share ("Preferred Stock"), at a value of $0.2155 per share, for an aggregate value of $2,155,000.

More from the filing

Item 2.01 Completion of an Acquisition or Disposition of Assets.
On July 29, 2024, Synergy Empire Limited ("we", "us" or the "Company"), executed an Acquisition and Stock Purchase Agreement ("the "Agreement") with Meluha Therapeutics Berhad ("Meluha"), a limited company incorporated under the laws of Malaysia, and the shareholders of Meluha.
Pursuant to the Agreement, we agreed to purchase 10,000,000 shares of Meluha (the "Meluha Shares"), representing all of the issued and outstanding shares of common stock of Meluha, which were held by all the shareholders of Meluha.

Quoted from Synergy Empire Ltd's Form 8-K/A.

This is the only completed acquisition Synergy Empire Ltd reported under Item 2.01 in the last twelve months.

Selling to Synergy Empire Ltd, or weighing an offer there?

Who runs it now, who owns it, where the money comes from and what to watch for, every claim linked to its source.

Order Full Report on Synergy Empire Ltd
Not ready to order?

Look up Synergy Empire Ltd and see what is on record before you decide.

Get the free Snapshot

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days of completing a significant acquisition or disposition of assets, under Item 2.01 of the report. The acquired company sometimes files one too, when the deal makes it a subsidiary of the buyer.

Every fact on this page is taken from one of those filings and linked to it: which company acquired which, the date the filing gives for completion, and the price when the filing states one in dollars, shown next to the sentence that states it. A filing states what was bought and on what terms; it rarely states why, and neither does this page.

Cite this page

Permanent URL: https://mentionfox.com/acquisitions/synergy-empire-meluha-therapeutics-berhad-2025-03-28
Last updated 2026-09-30
Primary record: SEC filing
Synergy Empire Ltd acquires Meluha Therapeutics Berhad for $2.2 million: completed 2025-03-28. MentionFox, 2026-09-30. https://mentionfox.com/acquisitions/synergy-empire-meluha-therapeutics-berhad-2025-03-28